Case Report: Successful immune checkpoint inhibitor-based rechallenge in a patient with advanced renal clear cell cancer

With the rapidly evolving of immune checkpoint inhibitors (ICIs), it has shown remarkable clinical benefits in treating various cancers. However, immune-related adverse events (irAEs) remain a significant challenge in the management of patients undergoing immunotherapy. There are limited data about...

Descripción completa

Detalles Bibliográficos
Autores principales: He, Shengxiu, Wang, Liang, Sun, Yan, Du, Huakun, Yu, Xiaomin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10616240/
https://www.ncbi.nlm.nih.gov/pubmed/37915573
http://dx.doi.org/10.3389/fimmu.2023.1270828

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10616240/
https://www.ncbi.nlm.nih.gov/pubmed/37915573
http://dx.doi.org/10.3389/fimmu.2023.1270828

Ejemplares similares